Euro euro euro to Cork Medical Facility

250 new jobs are being created this year due to the expansion.

GE HEALTHCARE grows its carrigohill site and strengthens Cork’s role as an important hub of pharmaceutical innovation

The new facility is expected to be operational by the end of 2027 and will increase production capacity by 25 million patient doses annually.

Taoiseach turns soot for the project this morning.

President and CEO of GE Healthcare’s Pharmaceutical Diagnostics (PDX) Segment, Kevin O’Neill, said,

“As an industry, we have a responsibility to help meet the growing global demand for contrast media from healthcare providers and their patients. This new facility demonstrates our broader commitment not only to meet future demand, but also to increase the elasticity and security of the industry’s supply to customers. “

Eugene Barrett, place leader and CEO, GE Healthcare Ireland, said:

“This expansion strengthens our long -standing presence in Cork, where we have a very skilled team, access to leading talent in the pharmaceutical industry, strong distribution connections around the world and a major partnership with Ida Ireland. First doses from our new facility are expected by the end of 2027, and we are proud of the influence our side will continue to do for patients around the world. “

Ida Ireland CEO Michael Lohan said:

“Today’s message from GE Healthcare to expand their production facility and related expertise in the production of vital drugs and create employment opportunities are very welcome. It is an endorsement from the GE Healthcare Senior Leadership Team of the confidence in the ability and competence of the team at Carrigohill -Campus, which was developed over three decades. I wish GE HEALTHCARE any success with this investment and assure them of Irel’s continued partnership and support. “